| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $320K | — |
| R&D Expense | $6.6M | +8.3% |
| SG&A Expense | $6.3M | -44.7% |
| Operating Income | -$12.6M | +53.7% |
| Pre-tax Income | -$11.2M | +54.9% |
| Income Tax | $0 | +100.0% |
| Net Income | -$11.2M | +54.2% |
| EPS (Basic) | -$0.78 | +95.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.7M | -24.8% |
| Current Assets | $17.9M | -19.8% |
| Total Assets | $18.3M | -19.4% |
| Current Liabilities | $8.4M | -22.2% |
| Total Liabilities | $8.4M | -22.2% |
| Stockholders' Equity | $9.8M | -16.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.8M | +14.6% |
| Capital Expenditures | $8K | -97.3% |
| Investing Cash Flow | -$8K | +97.3% |
| Financing Cash Flow | $10.6M | -71.1% |
| Free Cash Flow | -$14.8M | +16.0% |